Determination of Residual Nonsteroidal Anti-Inflammatory Drugs in Aqueous Sample Using Magnetic Nanoparticles Modified with Cetyltrimethylammonium Bromide by High Performance Liquid Chromatography

Table 4

Comparison of the proposed method with other analytical methods for the determination of different nonsteroidal anti-inflammatory drugs in various samples.

Analytical technique	Matrix	Linear range	𝑅^2	LOD	ER%	RSD%	Reference
HFLPME-HPLC (Ibu-Diclo)	Urine	(135–10000) ng/mL	>0.99	(41–53) ngmL^−1	99%		[9]
SPME-HPLC (Ibu)	Urine	(5–50) 𝜇gmL^−1	>0.98	5 𝜇gmL^−1	(3.7–5.7) %	<13.4	[6]
Supra molecular SPE-LC (Nap-Ibu)	Sewage	Ibu (0.2–750) ng; Nap (0.02–250) ng	>0.99; >0.99	0.8 ngmL^−1; 9 ngmL^−1	(93–101) %	(2–9) %	[8]
SPE-LC (Diclo-Indo)	Urine	(0.02–1.0) 𝜇gmL^−1	>0.99	0.007–0.035 𝜇gL^−1	(85-85) %	Diclo (0.95–9.8) %; Indo (0.62–8.7) %	[7]
MSPE-HPLC (NSAIDs)	Urine and sewage	(7–200) ng/mL	>0.99	(2–7) ng/mL	(91.76–96.24) %	(3.98–9.83) %	This work

SPME: solid phase micro extraction; SPE: solid phase extraction; HFLPME: hollow fiber liquid phase microextraction; MNP_s: magnetic nanoparticles.